cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n.1
title: 6,7-dimethyl-2-(tributylstannyl)quinoxaline
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367].
 The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]:
 InChI descriptor[cheminf_000113]: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;, and canonical SMILES descriptor[cheminf_000007]: CCCC[Sn](c1cnc2c(n1)cc(c(c2)C)C)(CCCC)CCCC, and by the IUPAC name[cheminf_000107]: .
 
 The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]:
 
 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-18551

 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]:
 Melting point descriptor[CHEMINF_000256]: 
 Boiling point descriptor[CHEMINF_000257]: 
 Refractive index descriptor[CHEMINF_000253]:

 The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]:
 
 CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 CHMO:0000470 | mass spectrometry (MS)
 
 CHMO:0000630 | infrared absorption spectroscopy (IR)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: 

 Used ontologies:
 CHEBI - Chemical Entities of Biological Interest
 CHEMINF - chemical information ontology (information entities about chemical entities)
 CHMO - Chemical Methods Ontology
 OBI - Ontology for Biomedical Investigations
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n/chmo0000470
title: mass spectrometry (MS) ()
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: dataset for mass spectrometry (MS)
 
 MS (FAB, 3-NBA), m/z (%): 449 (29) [M+H]+, 279 (32), 277 (100), 276 (47), 275 (72), 274 (31), 273 (38), 179 (28), 177 (28), 159 (65), 147 (26). HRMS–FAB (m/z): [M + H]+ calcd for C22H37N2120Sn1 449.1973; found 449.1974.
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) ()
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 1H NMR (400 MHz, CDCl3, ppm) δ = 0.88 (t, J = 7.3 Hz, 9H, CH3), 1.12–1.28 (m, 6H, CH2), 1.35 (h, J = 7.3 Hz, 6H, CH2), 1.51–1.72 (m, 6H, CH2), 2.47 (s, 6H, CH3), 7.76 (s, 1H, HAr), 7.87 (s, 1H, HAr), 8.70 (s, 1H, HAr).
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n/chmo0000596
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n/chmo0000630
title: infrared absorption spectroscopy (IR) ()
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: dataset for infrared absorption spectroscopy (IR)
 
 IR (ATR, ṽ) = 2953, 2919, 2870, 2850, 1625, 1553, 1511, 1480, 1455, 1418, 1375, 1356, 1340, 1315, 1290, 1247, 1234, 1196, 1179, 1169, 1149, 1105, 1075, 1045, 1023, 999, 955, 919, 868, 844, 823, 799, 769, 747, 735, 690, 669, 615, 598, 571, 558, 547, 507, 489, 479, 453, 422, 399, 390, 375 cm–1.
DOI: 10.14272/madgyeapsrgwqn-uhfffaoysa-n/chmo0000596.1
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C10H9N2.3C4H9.Sn/c1-7-5-9-10(6-8(7)2)12-4-3-11-9;3*1-3-4-2;/h3,5-6H,1-2H3;3*1,3-4H2,2H3;

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000595
title: 13C nuclear magnetic resonance spectroscopy (13C NMR) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 13C NMR (100 MHz, CDCl3, ppm) δ = 22.3 (CH3), 55.2 (2C, OCH3), 106.2 (CHO2), 128.2 (CH), 129.4 (CH), 129.4 (CH), 130.5 (CH), 139.9 (Cq), 141.4 (Cq), 150.9 (Cq), 153.4 (Cq).
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000630
title: infrared absorption spectroscopy (IR) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for infrared absorption spectroscopy (IR)
 
 IR (ATR, ṽ) = 3064, 2993, 2931, 2830, 1728, 1714, 1609, 1565, 1487, 1465, 1439, 1397, 1366, 1343, 1317, 1299, 1254, 1210, 1190, 1173, 1120, 1095, 1067, 1011, 996, 966, 928, 901, 875, 819, 788, 761, 722, 679, 613, 595, 561, 547, 490, 466, 442, 412, 384 cm–1.
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000593
title: 1H nuclear magnetic resonance spectroscopy (1H NMR) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 1H NMR (400 MHz, CDCl3, ppm) δ = 2.88 (s, 3H, CH3), 3.50 (s, 6H, OCH3), 5.55 (s, 1H, CHO2), 7.66–7.81 (m, 2H, HAr), 8.00–8.07 (m, 1H, HAr), 8.08–8.16 (m, 1H, HAr).
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000596
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000596.1
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n.1
title: 2-(dimethoxymethyl)-3-methylquinoxaline
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: This is a physical chemical entity[CHEBI_24431] associated with a molecule[CHEBI_25367].
 The molecule[CHEBI_25367] can be described by the following structural desciptors[cheminf_000085]:
 InChI descriptor[cheminf_000113]: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3, and canonical SMILES descriptor[cheminf_000007]: COC(c1nc2ccccc2nc1C)OC, and by the IUPAC name[cheminf_000107]: .
 
 The physical chemical entity[CHEBI_24431] has a component solvent[CHEBI_46787] which is described by the canonical SMILES descriptor[cheminf_000007]:
 
 The physical chemical entity[CHEBI_24431] has the following Sample ID as registered in the research data repository chemotion (www.chemotion-repository.net, https://doi.org/10.25504/FAIRsharing.iagXcR): CRS-20000

 The physical chemical entity[CHEBI_24431] can be described by the physical descriptors [CHEMINF_000025]:
 Melting point descriptor[CHEMINF_000256]: 93.0 - 94.0 (°C)
 Boiling point descriptor[CHEMINF_000257]: 
 Refractive index descriptor[CHEMINF_000253]:

 The physical chemical entity[CHEBI_24431] can be further described by the following assays[OBI:0000070][CHMO:0001133]:
 
 CHMO:0000593 | 1H nuclear magnetic resonance spectroscopy (1H NMR)
 
 CHMO:0000595 | 13C nuclear magnetic resonance spectroscopy (13C NMR)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000596 | distortionless enhancement with polarization transfer (DEPT)
 
 CHMO:0000470 | mass spectrometry (MS)
 
 CHMO:0000630 | infrared absorption spectroscopy (IR)
 
 The physical chemical entity[CHEBI_24431] was deposited to the Molecule Archive of the Karlsruhe Insitute of Technology (KIT) with the following Sample ID: 

 Used ontologies:
 CHEBI - Chemical Entities of Biological Interest
 CHEMINF - chemical information ontology (information entities about chemical entities)
 CHMO - Chemical Methods Ontology
 OBI - Ontology for Biomedical Investigations
DOI: 10.14272/umfrpxcwgohcre-uhfffaoysa-n/chmo0000470
title: mass spectrometry (MS) ()
title: InChI=1S/C12H14N2O2/c1-8-11(12(15-2)16-3)14-10-7-5-4-6-9(10)13-8/h4-7,12H,1-3H3

description: dataset for mass spectrometry (MS)
 
 MS (ESI), m/z (%): 219 (100) [M+H]+, 187 (72), 159 (16). HRMS–ESI (m/z): [M + H]+ calcd for C12H15N2O2 219.106; found 219.112.
DOI: 10.20391/fa9b31c6-4f27-45ef-a879-03cf99a82c86
title: WIO Skipjack tuna SNP dataset

description: A SNP dataset from individuals of Skipjack tuna collected from coastal sites in the Indian Ocean (Kenya, Tanzania, Mozambique, South Africa, Sri Lanka)
DOI: 10.6084/m9.figshare.21251816
title: Additional file 4 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 4.
DOI: 10.6084/m9.figshare.21251813.v1
title: Additional file 3 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 3.
DOI: 10.6084/m9.figshare.21251819
title: Additional file 5 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 5.
DOI: 10.6084/m9.figshare.21251810.v1
title: Additional file 2 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 2: Supplementary Table 1. The gene function notes of GO and KEGG enrichment analysis.
DOI: 10.6084/m9.figshare.21251813
title: Additional file 3 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 3.
DOI: 10.6084/m9.figshare.21251810
title: Additional file 2 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 2: Supplementary Table 1. The gene function notes of GO and KEGG enrichment analysis.
DOI: 10.6084/m9.figshare.21251816.v1
title: Additional file 4 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 4.
DOI: 10.6084/m9.figshare.21251819.v1
title: Additional file 5 of Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia

description: Additional file 5.
DOI: 10.20391/4923a998-5a10-4f91-8dd2-7ce88bbc3e13
title: SNP dataset for WIO Kawakawa

description: SNP dataset from individuals of Kawakawa collected across WIO (Kenya, Tanzania, Mozambique)
DOI: 10.6084/m9.figshare.21251861.v1
title: Additional file 2 of Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer

description: Additional file 2: Supplementary Table 1. The results of the GSEA.
DOI: 10.6084/m9.figshare.21251861
title: Additional file 2 of Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer

description: Additional file 2: Supplementary Table 1. The results of the GSEA.
DOI: 10.6084/m9.figshare.14436200.v1
title: Additional file 10 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 10: Pairwise correlations of combined blood module membership and two individual blood module memberships. This table reports the pairwise correlations between the summary blood MM measure and the two individual blood MM measures for each preserved module (yellow/CTX, blue/CTX, green/CTX, yellow/CN and blue/CB). The table shows that the summary MM measure adequately represents the individual measures. (XLS 22 KB)
DOI: 10.6084/m9.figshare.14436197
title: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?
DOI: 10.6084/m9.figshare.20729299
title: EFFECTS OF DIETARY SUPPLEMENTATION ON THE TRAINING OF FEMALE TENNIS PLAYERS IN HOT CLIMATES

description: ABSTRACT Introduction A tennis match may last up to four hours with long intervals between moves of medium to high exercise intensity for 10 minutes and aerobic characteristic that requires specific sources of energy. Inappropriate diets can negatively impact sports performance and delay the recovery phase. Fortified wheat germ protein powder has the supplementation characteristics required in aerobic activities, although there are no practical studies on its impacts on the work performance of female tennis athletes. Objective Explore the influence of two weeks of training in a warm environment combined with nutritional intervention on the performance of female tennis players. Methods It was observed by testing the immunological indices of elite female tennis players while training their changes and their effects on nutritional intervention. Results The increase in serum CK activity was closely related to the amount of exercise. Many studies have shown that serum CK activity increased significantly after strenuous exercise, and the serum CK value of subjects in the test group was significantly lower than that of the control group, showing better adaptability to exercise. Compared with before the nutritional intervention, the athletes’ weight decreased slightly, and the body fat percentage decreased significantly after the nutritional intervention. Compared with before nutritional intervention, sugar and salt supplements in athletes were significantly increased (P&lt;0.05). Sweating rate, hydration rate, and hydration/sudden rate were also significantly increased (P&lt;0.05). Conclusion Strengthening wheat germ protein supplementation may improve the nutritional albumin level in female tennis players, manifested in blood levels and immune function performance. Level of evidence II; Therapeutic studies - investigation of treatment outcomes.
DOI: 10.6084/m9.figshare.25225979.v1
title: Supplementary Material for: The Effect of Citric and Ascorbic Acids as Anti-Biofilm and Anti-Capsular Agents on Multidrug Resistant Acinetobacter baumannii

description: Objective: Acinetobacter baumannii (A. baumannii) is an opportunistic bacterium with multiple virulence factors, including capsule and biofilm, and is known for its high drug resistance. Anti-virulence natural substances have been suggested as novel alternatives to conventional antibiotics. We aimed to evaluate the effect of citric acid and ascorbic acid as anti-biofilm and anti-capsular agents against multidrug resistant (MDR) A. baumannii clinical isolates. Materials and Methods: Twenty-eight A. baumannii MDR isolates were collected from different clinical sources. The minimum inhibitory concentration (MIC) of each agent was estimated. Biofilm formation and capsule were investigated phenotypically in the absence and presence both agents at ½ and ¼ MICs. The presence of 14 adhesive and non-adhesive virulence genes was investigated. Results: Phenotypically, all the isolates were biofilm producers and were capsulated. The MIC of citric acid ranged from 1.25 to 2.5 mg/ml while that of ascorbic acid was 3 mg/ml for all isolates. Both agents showed significant reduction in biofilm and capsular thinning. Ascorbic acid showed a dose-dependent effect in both biofilm reduction and capsule thinning unlike citric acid. Four genes, papG23, sfa1, fyuA and cvaC, were absent among all isolates, while iutA was present in 100% of isolates. Other genes showed different distributions among the isolates. These virulence genes were not correlated to the antibiofilm effect of both agents. Ascorbic acid was observed to have a better effect than citric acid. This can provide a clue for a better treatment regimen including ascorbic acid against MDR A. baumannii infections.
DOI: 10.5281/zenodo.10154210
title: Data for "Influence of process energy on the formation of imperfections in BCCZ cells produced by LPBF from the magnesium alloy WE43"

description: The dataset used to supplement the article. The data were used to develop process parameters leading to high relative material density of BCCZ cells produced by laser power bed fusion. The data describe the influence of a wide range of process parameters on the material density, surface roughness and dimensional deviation of vertical and inclined struts and BCCZ cells with diameters of 0.5, 1, 2 and 3 mm.
DOI: 10.5281/zenodo.10154211
title: Data for "Influence of process energy on the formation of imperfections in BCCZ cells produced by LPBF from the magnesium alloy WE43"

description: The dataset used to supplement the article. The data were used to develop process parameters leading to high relative material density of BCCZ cells produced by laser power bed fusion. The data describe the influence of a wide range of process parameters on the material density, surface roughness and dimensional deviation of vertical and inclined struts and BCCZ cells with diameters of 0.5, 1, 2 and 3 mm.
DOI: 10.6084/m9.figshare.21251864
title: Additional file 3 of Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer

description: Additional file 3: Supplementary Table 2. Correlation statistics between CPSF3 and immune checkpoint-related genes.
DOI: 10.6084/m9.figshare.21251864.v1
title: Additional file 3 of Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer

description: Additional file 3: Supplementary Table 2. Correlation statistics between CPSF3 and immune checkpoint-related genes.
DOI: 10.6084/m9.figshare.14436257.v1
title: Additional file 6 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 6: Table of pairwise correlations between preserved CTX modules. Each preserved CTX module (yellow/CTX, blue/CTX and green/CTX) is represented by its eigengene. High positive or negative correlations between eigengenes suggest that the modules are indistinguishable. Correlations between the yellow/CTX, blue/CTX and green/CTX are reported. (XLS 25 KB)
DOI: 10.6084/m9.figshare.14436146.v1
title: Additional file 1 of High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis

description: Additional file 1: Supplement1.txt. Additional file 1 contains a list that maps internally used probe identifiers with identifiers used in the NCBI probe database. (TXT 8 KB)
DOI: 10.6084/m9.figshare.17057711.v1
title: Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models

description: Inactivated coronaviruses, including severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), as potential vaccines have been reported to result in enhanced respiratory diseases (ERDs) in murine and nonhuman primate (NHP) pneumonia models after virus challenge, which poses great safety concerns of antibody-dependent enhancement (ADE) for the rapid wide application of inactivated SARS-CoV-2 vaccines in humans, especially when the neutralizing antibody levels induced by vaccination or initial infection quickly wane to nonneutralizing or subneutralizing levels over the time. With passive transfer of diluted postvaccination polyclonal antibodies to mimic the waning antibody responses after vaccination, we found that in the absence of cellular immunity, passive infusion of subneutralizing or nonneutralizing anti-SARS-CoV-2 antibodies could still provide some level of protection against infection upon challenge, and no low-level antibody-enhanced infection was observed. The anti-SARS-CoV-2 IgG-infused group and control group showed similar, mild to moderate pulmonary immunopathology during the acute phase of virus infection, and no evidence of vaccine-related pulmonary immunopathology enhancement was found. Typical immunopathology included elevated MCP-1, IL-8 and IL-33 in bronchoalveolar lavage fluid; alveolar epithelial hyperplasia; and exfoliated cells and mucus in bronchioles. Our results corresponded with the recent observations that no pulmonary immunology was detected in preclinical studies of inactivated SARS-CoV-2 vaccines in either murine or NHP pneumonia models or in large clinical trials and further supported the safety of inactivated SARS-CoV-2 vaccines.
DOI: 10.6084/m9.figshare.14436200
title: Additional file 10 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 10: Pairwise correlations of combined blood module membership and two individual blood module memberships. This table reports the pairwise correlations between the summary blood MM measure and the two individual blood MM measures for each preserved module (yellow/CTX, blue/CTX, green/CTX, yellow/CN and blue/CB). The table shows that the summary MM measure adequately represents the individual measures. (XLS 22 KB)
DOI: 10.6084/m9.figshare.14436206
title: Additional file 12 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 12: Preserved hub genes list and their module membership values. This table report three lists of preserved hub genes selected in Figure 5. Their corresponding module membership values are also provided. (XLS 86 KB)
DOI: 10.6084/m9.figshare.14436212
title: Additional file 14 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 14: Relationship between modules and cluster of differentiation genes. Table of correlation coefficients (and p-values) between cluster of differentiation genes and preserved module eigengene (XLS 84 KB)
DOI: 10.6084/m9.figshare.14436146
title: Additional file 1 of High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis

description: Additional file 1: Supplement1.txt. Additional file 1 contains a list that maps internally used probe identifiers with identifiers used in the NCBI probe database. (TXT 8 KB)
DOI: 10.6084/m9.figshare.14436173.v4
title: Additional file of High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis

description: Additional file of High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis
DOI: 10.6084/m9.figshare.14436212.v1
title: Additional file 14 of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file 14: Relationship between modules and cluster of differentiation genes. Table of correlation coefficients (and p-values) between cluster of differentiation genes and preserved module eigengene (XLS 84 KB)
DOI: 10.6084/m9.figshare.14436197.v1
title: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?
DOI: 10.6084/m9.figshare.14436197.v4
title: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?

description: Additional file of Is human blood a good surrogate for brain tissue in transcriptional studies?